جميع الدراسات
التوظيفعلم الأدوية البشري (المرحلة الأولى) - أخرىتداخلي

A Single-Dose Pharmacokinetic Study of Lepodisiran in Participants with Varying Degrees of Liver Impairment and Participants with Normal Liver Function

This clinical trial is studying an experimental medicine called lepodisiran. The liver acts as a natural filter, breaking down medicines and clearing them from the bloodstream. When a person has liver problems, medicines can sometimes build up or clear out at different speeds. In this study, researchers want to see how the body absorbs, breaks down, and removes a single dose of lepodisiran. They will compare results between people with healthy livers and people with mild, moderate, or severe liver disease. Participants will receive one dose of the medicine and have regular blood tests and health checks. This information will help doctors understand whether future doses need to be adjusted for people with liver conditions. The study is open to adults aged 18 and over, and taking part is completely voluntary.

نظرة سريعة

الحالة
التوظيف
المرحلة
علم الأدوية البشري (المرحلة الأولى) - أخرى
الراعي
شركة إيلي ليلي وشركاه.
الهدف من التسجيل
6
ابدأ
16 Jun 2025

ما هو موضوع هذه الدراسة؟

When new medicines are created, scientists need to understand how they travel through the human body. This includes checking how the drug is absorbed, how it breaks down, and how it leaves the system. This early trial is testing an experimental medicine named lepodisiran to see how the body processes it.

The liver plays a vital role in processing many medicines. If someone has a liver condition, their liver may not process medicines in the normal way. This could mean a drug stays in the blood for longer, which might increase the risk of side effects. To make sure lepodisiran is safe for everyone, researchers need to compare how it behaves in people with healthy livers versus those with liver damage.

By comparing volunteers with normal liver function to those with mild, moderate, or severe liver problems, doctors can gather key safety details. The findings will help doctors decide whether people with liver conditions will need a lower dose or a different schedule if this medicine is approved in the future.

النقاط الرئيسية

  • Tests how the body handles a single dose of the medicine lepodisiran.
  • Compares adults with healthy livers to those with mild, moderate, or severe liver conditions.
  • Helps doctors calculate safe, accurate doses for future patients with liver disease.
  • Includes health checks and regular blood tests to track drug levels.
  • Taking part is voluntary, and you are free to stop at any time.

من قد يكون مؤهلاً؟

This trial is open to adults aged 18 and older. Both men and women may be able to join. The researchers are looking for two main groups of volunteers: people with healthy livers and people who have been diagnosed with mild, moderate, or severe liver conditions.

To ensure it is safe for you to take part, the study team will carry out health checks and blood tests. These tests will confirm how well your liver and kidneys are working and make sure you do not have any other medical conditions that would make taking part unsafe.

You may not be eligible if you take certain other medicines that could interfere with lepodisiran, or if you have recent serious health issues. The study doctors will review your complete medical history before you join.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. عمري لا يقل عن 18 عامًا.
  2. I have either normal liver function or a known mild, moderate, or severe liver condition.
  3. I am willing to attend clinic visits and have regular blood tests.
  4. I am able to give informed consent to take part.
  5. I can provide details of any regular medications I take.
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

Taking part involves receiving a single dose of lepodisiran. Before you receive the medicine, you will attend a screening appointment to check your overall health. This usually includes blood tests, urine tests, and checks of your heart and blood pressure. You may need to stay at the clinic or visit regularly over several days or weeks so staff can take blood samples to measure medicine levels. Total time in the study will be discussed with you beforehand, and staff will monitor you closely for any changes in your health.

المخاطر والفوائد المحتملة

Because this is an early-stage pharmacology study, taking part is not expected to improve your health or treat your liver condition directly. However, the study provides detailed health monitoring, and your participation helps doctors learn how to treat future patients safely. Like all new medicines, lepodisiran may cause unexpected side effects or mild discomfort from procedures like blood tests. Your safety is closely watched at all times, and you can choose to leave the study at any point without it affecting your regular NHS medical care.

المواقع (1)

بعض مواقع الأماكن تقريبية. نحن نعمل على تحسين ذلك — يرجى التحقق مع فريق التجربة قبل السفر.
  • —
    غير مؤكد
    المجر

أسئلة شائعة

ما هو الهدف الرئيسي من هذه الدراسة؟

The goal is to see how different levels of liver health affect the way the body processes a single dose of lepodisiran.

Will this medicine treat my liver disease?

No. This study is not designed to treat or cure liver disease. It only looks at how the body handles the medicine.

كيف يتم إعطاء الدواء؟

Lepodisiran is given as a single dose during the trial, and the study team will guide you on how it is administered.

Do I have to pay to take part?

No, you do not pay for the study medicine or tests. Travel costs and time are often reimbursed by the study team.

هل يمكنني مغادرة الدراسة إذا غيرت رأيي؟

Yes. You are free to withdraw from the trial at any time, for any reason, without your normal medical care being affected.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "A Single-Dose Pharmacokinetic Study of Lepodisiran in Partic… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.